UPDATE : Friday, June 22, 2018
상단여백
Sillajen unveils trial results for cancer treatment at US conference by Lee Han-soo 2018-05-17 18:01
Sanofi Genzyme Korea gets 2nd line coverage for prostate cancer drug by Marian Chu 2018-05-17 18:01
KCDC finds Gram-negative bacteria infection in mass sepsis infection case by Marian Chu 2018-05-17 18:01
Samsung BioLogics shares fall 4% ahead of FSC review over alleged accounting fraud by Marian Chu 2018-05-17 18:00
SNUH conducts over 200 laparoscopic liver transplants by Lee Han-soo 2018-05-17 18:00
라인
Refusals of off-label drugs spiked last year by Nam Doo-hyun 2018-05-17 15:23
Ildong, Olix agree to develop macular degeneration treatment by Lee Han-soo 2018-05-17 14:18
Hugel completes P1 clinical trial on hypertrophic scar treatment by Lee Han-soo 2018-05-17 11:50
Dongwha, Hugel boost Q1 earnings under new CEO by So Jae-hyeon 2018-05-17 11:45
Allergan Korea appoints Kim Ji-hyun as new CEO by Marian Chu 2018-05-17 11:36
라인
US approves Daewoong’s Nabota plant by Marian Chu 2018-05-16 18:34
Ministry approves Korea’s first AI-based medical device by Lee Han-soo 2018-05-16 16:04
‘Biosimilars are better than originals’ by Park Gi-taek 2018-05-16 15:56
HIRA opens training program for Thailand health authorities by Marian Chu 2018-05-16 15:21
Hanyang rheumatic disease hospital to focus on intractable diseases by So Jae-hyeon 2018-05-16 15:21
라인
‘Proton therapy killed tumor in 70% of liver cancer patients’ by Marian Chu 2018-05-16 14:16
Jeil Pharma opens new tech research center by Lee Han-soo 2018-05-16 14:14
How China’s scrapping of tariffs will affect Korea’s drug exports? by Nam Doo-hyun 2018-05-16 12:14
Celltrion posts ₩245 billion in Q1 sales thanks to biosimilar uptake by Marian Chu 2018-05-16 12:13
Will Korean bio stocks rebound as MSCI includes Celltrion, Viromed, HLB? by Marian Chu 2018-05-16 11:25
여백
여백
여백
Back to Top